2m 2m 2m 2m 2m 2m 2m
ALX ONCOLOGY (ALXO)
NASDAQ
$1.94$0.00 (0.00%)
Price as of Sep 11, 2026 7:30 PM EDT- $268.3MMarket Cap
- 83.02%1-Year Change
- BiotechnologyIndustry
ALX ONCOLOGY (ALXO)
$1.94$0.00 (0.00%)
ALXO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.94 | ||
Change | +$0.04 (+2.11%) | ||
Open | $1.91 | ||
High | $2.00 | ||
Low | $1.85 | ||
Previous Close | $1.90 | ||
Volume | 1,036,362 | ||
30-Day Average Volume | 768,237 | ||
1-Week Change | -3.48% | ||
1-Month Change | 0.52% | ||
1-Year Change | 83.02% | ||
3-Year Change | -60.89% | ||
5-Year Change | -97.50% | ||
Fundamentals | |||
Shares Outstanding | 138.3M | ||
Total Assets | $160.8M | ||
Market Cap | $268.3M | ||
Enterprise Value | $255.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$17.7M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $128.7M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue